DOCTORS'
Medical Case Studies
1) Can you furnish an opinion on the treatment currently in progress? 2) What do you think of the possibility ... estimation of her chances to benefit from the consequent radionuclide treatment, should be conducted by a well experienced team. I ...
on Nov 2007, admitted to DH to begin treatment with Tarceva 150 mg/day for 1 month; - ... problems should not be underestimated after repeated radionuclide therapies. 4. Any other treatments ...
that time point). On 11/2007 the treatment was switched to Tarceva for 1 month (the reasons for starting ... of therapy, namely with somatostatin receptor targeted radionuclide therap y . I would, therefore, recommend presenting her ...